Overview
Mahesha Makandura is a Rheumatologist in Novi, Michigan. Dr. Makandura is rated as an Experienced provider by MediFind in the treatment of Rhizomelic Pseudopolyarthritis. Her top areas of expertise are Polymyalgia Rheumatica and Rhizomelic Pseudopolyarthritis. Dr. Makandura is currently accepting new patients.
Her clinical research consists of co-authoring 1 peer reviewed article. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 1 article in the study of Rhizomelic Pseudopolyarthritis.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- HMO
- POS
- PPO
- HMO
- EPO
- HMO
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- EPO
- MANAGED MEDICAID PLAN
- OTHER COMMERCIAL
- OTHER MANAGED MEDICAID
- HMO
- OTHER MEDICAID
- STATE MEDICAID
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- INSURANCE PLAN
- MEDICARE MAPD
- OTHER COMMERCIAL
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER COMMERCIAL
- OTHER COMMERCIAL
- EPO
- HMO
- POS
- PPO
- MEDICARE DISCOUNT CARD
- MEDICARE PDP
- OTHER MEDICARE
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
39450 W 12 Mile Rd, Novi, MI 48377
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Arthritis Specialists Of Michigan
Joseph Skender is a Rheumatologist in Royal Oak, Michigan. Dr. Skender is rated as a Distinguished provider by MediFind in the treatment of Rhizomelic Pseudopolyarthritis. His top areas of expertise are Rheumatoid Arthritis (RA), Rhizomelic Pseudopolyarthritis, Polymyalgia Rheumatica, and Fibromyalgia. Dr. Skender is currently accepting new patients.
University Of Toledo Physicians LLC
Nezam Altorok is a Rheumatologist in Toledo, Ohio. Dr. Altorok has been practicing medicine for over 16 years and is rated as a Distinguished provider by MediFind in the treatment of Rhizomelic Pseudopolyarthritis. His top areas of expertise are Scleroderma, Rhizomelic Pseudopolyarthritis, Polymyalgia Rheumatica, Endoscopy, and Gastrostomy. Dr. Altorok is currently accepting new patients.
Henry Ford Health System
Ali Amin is a Rheumatologist in Taylor, Michigan. Dr. Amin is rated as an Advanced provider by MediFind in the treatment of Rhizomelic Pseudopolyarthritis. His top areas of expertise are Rhizomelic Pseudopolyarthritis, Rheumatoid Arthritis (RA), Polymyalgia Rheumatica, and Fibromyalgia. Dr. Amin is currently accepting new patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Polymyalgia RheumaticaDr. Makandura isExperienced. Learn about Polymyalgia Rheumatica.
- Rhizomelic PseudopolyarthritisDr. Makandura isExperienced. Learn about Rhizomelic Pseudopolyarthritis.